Literature DB >> 12091179

Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema.

Graziella Turato1, Renzo Zuin, Massimo Miniati, Simonetta Baraldo, Federico Rea, Bianca Beghé, Simonetta Monti, Bruno Formichi, Piera Boschetto, Sergio Harari, Alberto Papi, Piero Maestrelli, Leonardo M Fabbri, Marina Saetta.   

Abstract

The lung pathology of severe chronic obstructive pulmonary disease (COPD) has been poorly investigated. We examined surgical specimens obtained from patients with severe (forced expiratory volume in 1 second [FEV(1)] = 29 +/- 3% predicted, n = 9) or mild/no airflow limitation (FEV(1) = 86 +/- 5% predicted, n = 9) and similar smoking history. With histochemical and immunohistochemical methods we quantified the structural changes and the inflammatory cells in small airways and in muscular pulmonary arteries. As compared with smokers with mild/no COPD, smokers with severe COPD had an increased number of leukocytes in the small airways, which showed a positive correlation with the radiologic score of emphysema and with the value of residual volume, and a negative correlation with the values of FEV(1) and carbon monoxide diffusing capacity. The inflammatory process was characterized by an increase in CD8(+) and CD4(+) T-lymphocytes in the airway wall and by an increase in macrophages in the airway epithelium. When all smokers were considered together, the smoking history was correlated with both the airway wall and smooth muscle thickness, suggesting that smoking itself may play a role in the development of structural changes. No structural and cellular differences were observed in pulmonary arteries between smokers with severe COPD and smokers with mild/no COPD. In conclusion, in the small airways of smokers with severe COPD, there is an increased number of leukocytes, which is correlated with reduced expiratory flow, lung hyperinflation, carbon monoxide diffusion impairment, and radiologic emphysema, suggesting a role for this inflammatory response in the clinical progression of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091179     DOI: 10.1164/rccm.2111084

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  40 in total

1.  Early emphysema in the tight skin and pallid mice: roles of microfibril-associated glycoproteins, collagen, and mechanical forces.

Authors:  Satoru Ito; Erzsébet Bartolák-Suki; J Michael Shipley; Harikrishnan Parameswaran; Arnab Majumdar; Bélâ Suki
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-26       Impact factor: 6.914

2.  Saikosaponin a Inhibits Cigarette Smoke-Induced Oxidant Stress and Inflammatory Responses by Activation of Nrf2.

Authors:  Ru-Jie Chen; Xian-Yang Guo; Bi-Huan Cheng; Yu-Qiang Gong; Bin-Yu Ying; Meng-Xiang Lin
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

3.  Acetylation of lysine 9 on histone H3 is associated with increased pro-inflammatory cytokine release in a cigarette smoke-induced rat model through HDAC1 depression.

Authors:  Xi Chen; Xiao-jun Guan; Xiao-hua Peng; Zhi-lei Cui; Chun-yu Luan; Xue-jun Guo
Journal:  Inflamm Res       Date:  2015-06-02       Impact factor: 4.575

4.  The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model.

Authors:  A G Jarnicki; H Schilter; G Liu; K Wheeldon; A-T Essilfie; J S Foot; T T Yow; W Jarolimek; P M Hansbro
Journal:  Br J Pharmacol       Date:  2016-10-12       Impact factor: 8.739

Review 5.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

Review 6.  Evaluation of Individuals at Risk for COPD: Beyond the Scope of the Global Initiative for Chronic Obstructive Lung Disease.

Authors:  Julio D Antuni; Peter J Barnes
Journal:  Chronic Obstr Pulm Dis       Date:  2016-06-28

Review 7.  Airway gene expression in chronic obstructive pulmonary disease.

Authors:  Katrina Steiling; Marc E Lenburg; Avrum Spira
Journal:  Proc Am Thorac Soc       Date:  2009-12

8.  Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3.

Authors:  Steven G Kelsen; Mark O Aksoy; Mary Georgy; Richard Hershman; Rong Ji; Xiuxia Li; Matthew Hurford; Charalambos Solomides; Wissam Chatila; Victor Kim
Journal:  Am J Respir Crit Care Med       Date:  2009-02-12       Impact factor: 21.405

Review 9.  How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?

Authors:  Yohannes Mebratu; Yohannes Tesfaigzi
Journal:  Cell Cycle       Date:  2009-04-11       Impact factor: 4.534

Review 10.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.